MH
Therapeutic Areas
XORTX Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Oxypurinol (XRX-OXY) | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 3 |
| XRX-008 | Renal Disease associated with Type 2 Diabetes | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Oxypurinol (XRX-OXY) | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 3 |
| XRX-008 | Renal Disease associated with Type 2 Diabetes | Preclinical |